Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

By J. Toole, M. Malinow, L. Chambless, J. Spence, L. Pettigrew, Ron Howard, Elizabeth G. Sides, Christina Wang, MR Stampfer, T. Erlinger and 9 more. Journal of the American Medical Association (JAMA), 2004

1,413 citations recorded by the source corpus.

Subfields: Neurology, Physiology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/0eed3b42153952217b0d48753d69f237e722b469

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Islam
2. P. Joshi
3. S. Yusuf
4. S. Rangarajan
5. P. Pais
6. S. Reddy
7. S. Mendis
8. Prabhakaran Dorairaj

Citations in the corpus

• Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, methodology): “One examined B vitamin supplementation among patients with hyperhomocysteinemia and a recent ischemic stroke.(8) The other examined vitamin B supplementation among a broader range of patients with a”
• Guidelines for the Primary Prevention of Stroke (2011, neutral): “80).(793,794) Similarly, in the HOPE 2 study of patients with established”
• Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. (2007, background): “The role of other novel risk factors such as lipoprotein(a) or homocysteine, which are elevated in South Asians, in causing CHD is unclear.”